Bernadette Hensen

Bernadette Hensen

Auto-generated profile, based on publicly available information

Bernadette Hensen

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2021 in Health Policy and Planning
Verified
Journal Article
Open access
PDF file
BHB Hensen
B Hensen
CMC R S Mackworth-Young
C R S Mackworth-Young
MSM Simwinga
M Simwinga
NANada Abdelmagid
Nada Abdelmagid
JBJ Banda
J Banda
HWHelen Weiss
Helen Weiss
The coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus, has had unprecedented impacts on health systems, public health, societies and individuals globally ( The Lancet Public Health, 2020). In response to outbreaks, physical distancing measures, national lockdowns and travel restrictions to control the spread of COVID-19 have been implemented in many countries ( Chu et al., 2020). In response to these measures, many public health researchers are choosing to switch from standard face-to-face data collection methods to remote data collection in support of continued research. Remote data collection is defined here as the collection of data via the phone, online or other virtual platforms, with study participants and researchers physically distanced.

10 September 2014 in AIDS
Verified
Journal Article
Open access
BHBernadette Hensen
Bernadette Hensen
STSachiko Taoka
Sachiko Taoka
JLJames J. Lewis
James J. Lewis
HWHelen A. Weiss
Helen A. Weiss
JHJames Hargreaves
James Hargreaves
This systematic review summarizes evidence on the effectiveness of strategies to increase men's HIV-testing in sub-Saharan Africa. Medline, EmBase, Africa-Wide Information and Global Health were searched. Cluster and individually randomized trials evaluating interventions to increase the proportion of adults (≥ 15 years) testing for HIV were eligible if they were conducted in sub-Saharan Africa, included men in the study population, and reported HIV-testing data by sex. References were independently screened. Of the 1852 references, 15 papers including 16 trials were eligible. Trials were judged too heterogeneous to combine in meta-analysis. Three interventions invited men to attend antenatal care-based HIV-testing via pregnant partners, of which two showed a significant effect on partner-testing. One intervention invited men to HIV-test through pregnant partners and showed an increase in HIV-testing when it was offered in bars compared with health facilities. A trial of notification to partners of newly diagnosed HIV-positive patients showed an increase in testing where notification was by healthcare providers compared with notification by the patient. Three interventions reached men already at health facilities and eight reported the effects of community-based HIV testing. Mobile-testing had a significant effect on HIV-testing compared with standard voluntary counselling and testing. Home-based testing also had a significant effect, but reached smaller numbers of men than mobile-testing. Interventions to encourage HIV-testing can increase men's levels of HIV testing. Community-based programmes in particular had a large effect on population levels of HIV-testing. More data on costs and potential population impact of these approaches over different time-horizons would aid policy-makers in planning resource allocation to increase male HIV-testing.

27 October 2011 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
PDF file
BHBernadette Hensen
Bernadette Hensen
RBRachel Baggaley
Rachel Baggaley
VWVincent J. Wong
Vincent J. Wong
KGKristina L. Grabbe
Kristina L. Grabbe
NSNathan Shaffer
Nathan Shaffer
JHJames Hargreaves
James Hargreaves

25 July 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
IBIsolde Birdthistle
Isolde Birdthistle
SSSusie Schaffnit
Susie Schaffnit
DKDaniel Kwaro
Daniel Kwaro
MSMaryam Shahmanesh
Maryam Shahmanesh
ZZZiraba Ziraba
Ziraba Ziraba
SFSian Floyd
Sian Floyd
HIV risk remains unacceptably high among adolescent girls and young women (AGYW) in southern and eastern Africa, reflecting structural and social inequities that drive new infections. In 2015, PEPFAR (the United States President’s Emergency Plan for AIDS Relief) with private-sector partners launched the DREAMS Partnership, an ambitious package of interventions in 10 sub-Saharan African countries. DREAMS aims to reduce HIV incidence by 40% among AGYW over two years by addressing multiple causes of AGYW vulnerability. This protocol outlines an impact evaluation of DREAMS in four settings. To achieve an impact evaluation that is credible and timely, we describe a mix of methods that build on longitudinal data available in existing surveillance sites prior to DREAMS roll-out. In three long-running surveillance sites (in rural and urban Kenya and rural South Africa), the evaluation will measure: (1) population-level changes over time in HIV incidence and socio-economic, behavioural and health outcomes among AGYW and young men (before, during, after DREAMS); and (2) causal pathways linking uptake of DREAMS interventions to ‘mediators’ of change such as empowerment, through to behavioural and health outcomes, using nested cohort studies with samples of ~ 1000–1500 AGYW selected randomly from the general population and followed for two years. In Zimbabwe, where DREAMS includes an offer of pre-exposure HIV prophylaxis (PrEP), cohorts of young women who sell sex will be followed for two years to measure the impact of ‘DREAMS+PrEP’ on HIV incidence among young women at highest risk of HIV. In all four settings, process evaluation and qualitative studies will monitor the delivery and context of DREAMS implementation. The primary evaluation outcome is HIV incidence, and secondary outcomes include indicators of sexual behavior change, and social and biological protection. DREAMS is, to date, the most ambitious effort to scale-up combinations or ‘packages’ of multi-sectoral interventions for HIV prevention. Evidence of its effectiveness in reducing HIV incidence among AGYW, and demonstrating which aspects of the lives of AGYW were changed, will offer valuable lessons for replication.

1 September 2012 in Bulletin of the World Health Organization
Verified
Journal Article
Open access
RBR Baggaley
R Baggaley
BHB Hensen
B Hensen
OAO Ajose
O Ajose
KGKl Grabbe
Kl Grabbe
VWVj Wong
Vj Wong
JHJ Hargreaves
J Hargreaves
To describe recent changes in policy on provider-initiated testing and counselling (PITC) for human immunodeficiency virus (HIV) infection in African countries and to investigate patients' experiences of and views about PITC. A review of the published literature and of national HIV testing policies, strategic frameworks, plans and other relevant documents was carried out. Of the African countries reviewed, 42 (79.2%) had adopted a PITC policy. Of the 42, all recommended PITC for the prevention of mother-to-child HIV transmission, 66.7% recommended it for tuberculosis clinics and patients, and 45.2% for sexually transmitted infection clinics. Moreover, 43.6% adopted PITC in 2005 or 2006. The literature search identified 11 studies on patients' experiences of and views about PITC in clinical settings in Africa. The clear majority regarded PITC as acceptable. However, women in antenatal clinics were not always aware that they had the right to decline an HIV test. Policy and practice on HIV testing and counselling in Africa has shifted from a cautious approach that emphasizes confidentiality to greater acceptance of the routine offer of HIV testing. The introduction of PITC in clinical settings has contributed to increased HIV testing in several of these settings. Most patients regard PITC as acceptable. However, other approaches are needed to reach people who do not consult health-care services.

27 April 2021 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
SCSungai T Chabata
Sungai T Chabata
BHBernadette Hensen
Bernadette Hensen
TCTarisai Chiyaka
Tarisai Chiyaka
PMPhillis Mushati
Phillis Mushati
SMSithembile Musemburi
Sithembile Musemburi
FCFrances M Cowan
Frances M Cowan
Introduction Young women who sell sex (YWSS) in Zimbabwe remain at high risk of HIV infection. Effective HIV prevention strategies are needed. Through support to access a combination of evidence-based interventions, including oral pre-exposure prophylaxis (PrEP), the Determined, Resilient, Empowered, AIDS-free, Mentored and Safe (DREAMS) partnership aimed to reduce new HIV infections among adolescent girls and young women by 40% over 24 months. Methods Non-randomised ‘plausibility’ evaluation, powered to detect a 40% HIV incidence difference between DREAMS and non-DREAMS sites. Two large cities with DREAMS funding were included, and four smaller non-DREAMS towns for comparison. In all sites, YWSS were enrolled to a cohort through peer-referral. Women were followed up for 24 months. HIV seroconversion was the primary outcome, with secondary outcomes identified through a theory of change. Outcomes were compared between YWSS recruited in DREAMS cities and non-DREAMS towns, adjusting for individual-level confounders and HIV prevalence at enrolment. Results From April to July 2017, 2431 women were enrolled, 1859 of whom were HIV negative at enrolment; 1019 of these women (54.8%) were followed up from March to May 2019 and included in endline analysis. Access to clinical services increased, but access to socioeconomic interventions promoted by DREAMS was limited. A total of 79 YWSS HIV seroconverted, with HIV incidence among YWSS in DREAMS cities lower (3.1/100 person-years) than in non-DREAMS towns (5.3/100 person-years). In prespecified adjusted analysis, HIV incidence was lower in DREAMS cities but with weak statistical evidence (adjusted rate ratio (RR)=0.68; 95% CI 0.40 to 1.19; p=0.18). Women in DREAMS cities were more likely to report ever and ongoing PrEP use, consistent condom use, fewer sexual partners and less intimate partner violence. Conclusion It is plausible that DREAMS lowered HIV incidence among YWSS in two Zimbabwean cities, but our evaluation provides weak statistical evidence for impact and suggests any reduction in incidence was lower than the anticipated 40% decline. We identified changes to some important ‘pathways to impact’ variables, including condom use.